Monitor for additional insider sales, particularly from C-suite executives, which would carry more weight. The director's sale could be liquidity-driven (diversification, tax planning) rather than a bearish signal. The 10% owner's small buy provides no meaningful counter-signal. No immediate trading action warranted.
Price Chart
Executive Summary
Two insiders at Starling Oncology traded in opposite directions within a week: Director Brad Hively sold $1.95M worth of stock (298.9K shares at $6.51), while 10% owner Jorey Chernett bought $78K worth (12K shares at $6.54). The sale is large in absolute terms (~0.3% of market cap) but is a single director's open-market sale, which carries limited informational weight per the academic literature. The buy is small and from a 10% owner, not C-suite. The mixed net direction and lack of C-suite participation make this cluster neutral — no strong signal for traders.
Key Financial Metrics
Key Facts
- Director Brad Hively sold 298,853 shares at $6.5126 for total proceeds of $1,946,310 — a single open-market sale by a non-C-suite insider.
- 10% owner Jorey Chernett bought 12,000 shares at $6.54 for $78,480 — a small open-market purchase by a non-C-suite insider.
- Total cluster value is $2.02M (~0.3% of $659M market cap), with net direction mixed (one sell, one buy).
- No C-suite executives (CEO, CFO, COO) participated in either trade, reducing the signal strength of the cluster.
- The company has 91% bullish analyst consensus (10 of 11 analysts rate Buy or Strong Buy).
Financial Impact
Director sale of ~$1.95M represents ~0.3% of market cap; 10% owner purchase of ~$78K is negligible at ~0.01% of market cap.
Risk Factors
- Director sale could precede additional insider selling if other insiders follow.
- No C-suite buying to offset the director sale — lack of insider confidence signal.
- Stock is near $6.51; further insider selling could pressure the price.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-STLN-1787645688035 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 7w ago | 8-K | $6.09 $6.32 | ▲ +3.78% | ▲ +3.86% | $6.59 (+8.21%) |
Aug 24, 2026 9w ago | Insider Cluster | $6.30 $6.82 | ▲ +8.25% | ▲ +8.01% | $6.59 (+4.60%) |
Aug 17, 2026 10w ago | Insider Buy | $6.31 $6.37 | ▲ +0.95% | ▲ +2.93% | $6.59 (+4.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers